You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Case Challenges in the Comprehensive Management of Frequent Headache

  • Authors: Deborah I. Friedman, MD, MPH, FAAN
  • CME / ABIM MOC Released: 5/5/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 5/5/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for neurologists, migraine specialists, primary care physicians, and other healthcare providers who care for patients with frequent migraine.

The goal of this activity is to improve the ability of clinicians to recognize patients who are candidates for preventative therapies and utilize an appropriate calcitonin gene-related peptide (CGRP) monoclonal antibody (mAb).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Symptoms indicative of a migraine headache
  • Have greater competence related to
    • The identification of patients who are candidates for preventive migraine therapy
    • Personalizing the selection of preventive migraine therapies


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Deborah I. Friedman, MD, MPH, FAAN

    Professor
    Departments of Neurology and Ophthalmology
    Founding Director, Division of Headache Medicine
    University of Texas Southwestern Medical Center 
    Dallas, Texas

    Disclosures

    Disclosure: Deborah I. Friedman, MD, MPH, FAAN, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Allergan; Biohaven Pharmaceuticals; Eli Lilly; Impel NeuroPharma; Invex; Lundbeck; Revance Therapeutics; Satsuma Pharmaceuticals; Teva Pharmaceuticals; Theranica; Zosano
    Received grants for clinical research from: AbbVie; Allergan; Eli Lilly; Zosano

Steering Committee

  • Richard B. Lipton, MD

    Edwin S Lowe Professor of Neurology 
    Professor of Neurology, Psychiatry, and Epidemiology 
    Vice Chair 
    Saul R. Korey Department of Neurology 
    Albert Einstein College of Medicine 
    Director 
    Montefiore Headache Center 
    Montefiore Medical Center 
    New York, New York 

    Disclosures

    Disclosure: Richard B. Lipton, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: AbbVie; Alder; Allergan; Amgen; Biohaven; Dr. Reddy's; Electrocore; Eli Lilly & Company; Equinox; GlaxoSmithKline; Grifols; Lundbeck, Inc.; Merck; Pernix; Pfizer; Promius; Teva; Vedanta 
    Served as a speaker or a member of a speakers bureau for: AbbVie; Alder; Allergan; Amgen; Biohaven; Eli Lilly & Company; eNeura; Equinox; GlaxoSmithKline; Grifols; Lundbeck, Inc.; Teva 
    Received grants for clinical research from: AbbVie; Allergan; Amgen; Biohaven; Dr. Reddy's; Electrocore; Eli Lilly & Company; Grifols; Lundbeck, Inc.; Promius 
    Owns stock, stock options, or bonds from: Biohaven; Ctrl M Health 

  • Jessica Ailani, MD

    Director 
    MedStar Georgetown Headache Center 
    Vice Co-Chair, Strategic Planning 
    Medstar Neurology 
    Professor of Clinical Neurology 
    Department of Neurology 
    Medstar Georgetown University Hospital 
    Washington, DC 

    Disclosures

    Disclosure: Jessica Ailani, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: AbbVie; Allergan; Amgen; Axsome Therapeutics; Biohaven; Ctrl M Health; Eli Lilly & Company; Impel; Satsuma; Teva; Theranica; Vorso 
    Served as a speaker or a member of a speakers bureau for: AbbVie; Allergan; Amgen; Biohaven; Eli Lilly & Company; Teva 
    Received grants for clinical research from: AbbVie; Allergan; Biohaven; Eli Lilly & Company; Satsuma; Teva; Zosano 
    Owns stock, stock options, or bonds from: Ctrl M Health 

  • Dawn C. Buse, PhD

    Clinical Professor 
    Department of Neurology 
    Albert Einstein College of Medicine 
    Assistant Professor 
    Clinical Health Psychology Doctoral Program 
    Ferkauf Graduate School of Psychology 
    Yeshiva University 
    New York, New York 

    Disclosures

    Disclosure: Dawn C. Buse, PhD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Alder; Allergan; Amgen; Biohaven; Eli Lilly & Company; Lundbeck, Inc.; Teva 
    Received grants for clinical research from: Amgen 

  • David W. Dodick, MD

    Professor of Neurology 
    Director of Headache Medicine 
    Mayo Clinic Arizona 
    Phoenix, Arizona 

    Disclosures

    Disclosure: David W. Dodick, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: AEON; Alder; Allergan; Biohaven; Amgen; Cerecin; Clexio; CME Outfitters; Cooltech; Ctrl M Health; Curry Rockefeller Group; Eli Lilly & Company; eNeura; Equinox; Impel; Linpharma; Lundbeck, Inc.; Nocira; Novartis; Pieris; Praxis; Promius; Revance; Satsuma; Theranica; Upjohn; WL Gore; XoC; Zosano 
    Served as a speaker or a member of a speakers bureau for: AEON; Alder; Allergan; Amgen; Biohaven; Cerecin; Clexio; Cooltech; Ctrl M Health; Eli Lilly & Company; eNeura; Impel; Linpharma; Lundbeck, Inc.; Nocira; Novartis; Pieris; Praxis; Promius; Satsuma; Theranica; Upjohn; WL Gore; XoC; Zosano 

  • Larry C. Newman, MD

    Professor of Neurology 
    NYU Grossman School of Medicine 
    Director 
    Headache Division 
    NYU Langone Medical Center 
    New York, New York 

    Disclosures

    Disclosure: Larry C. Newman, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Allergan; Amgen; Biohaven; Eli Lilly & Company; Lundbeck, Inc.; Supernus; Teva 
    Other: Royalty -- Oxford University Press 

  • Amaal J. Starling, MD

    Associate Professor of Neurology  
    Mayo Clinic Alix School of Medicine  
    Consultant  
    Department of Neurology  
    Mayo Clinic Arizona  
    Scottsdale, Arizona 

    Disclosures

    Disclosure: Amaal J. Starling, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Allergan; Amgen; Axsome Therapeutics; Eli Lilly & Company; Impel; Lundbeck, Inc.; Med-IQ; Novartis; Teva; Theranica 

Editors

  • Kathy Merlo

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Kathy Merlo has disclosed no relevant financial relationships.

  • Ruwaida Vakil, MSc

    Medical Writer, Medscape, LLC

    Disclosures

    Disclosure: Ruwaida Vakil, MSc, has disclosed the following relevant financial relationships:
    Owns stock, stock options, or bonds from: Pfizer

CME Reviewer

  • Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP, CHCP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Case Challenges in the Comprehensive Management of Frequent Headache

Authors: Deborah I. Friedman, MD, MPH, FAANFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 5/5/2021

Valid for credit through: 5/5/2022

processing....

AAN = American Academy of Neurology
AE = adverse event
AHS = American Headache Society
AMPP = American Migraine Prevalence and Prevention
BMI = body mass index
BP = blood pressure
bpm = beats per minute
CaMEO = Chronic Migraine Epidemiology and Outcomes
CGRP = calcitonin gene-related peptide
FDA = US Food and Drug Administration
ICHD-3 = International Classification of Headache Disorders 3rd Edition
HEENT = head, eyes, ears, nose, and throat
HIT = Headache Impact Test
mAb = monoclonal antibody
MHD = monthly headache day
MIDAS = Migraine Disability Assessment
MMD = monthly migraine day
NSAID = nonsteroidal anti-inflammatory drug
OTC = over the counter
QoL = quality of life
SEEDS = sleep, exercise, eat, diary, and stress
T = temperature

« Return to: Case Challenges in the Comprehensive Management of Frequent Headache
  • Print